Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1265099 | 0.91 | TSHR (0.45) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL2320779 | 0.83 | THRB (0.48) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL3283448 | 0.82 | THRB (0.46) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL21314238 | 0.80 | THRB (0.46) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL1269730 | 0.80 | POLB (0.45) | THRBTSHRALDH1A1 | |
| SCHEMBL57853 | 0.79 | THRB (0.50) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL29612237 | 0.79 | THRB (0.50) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL106660 | 0.78 | ALDH1A1 (0.40) | TSHRALDH1A1TP53HIF1AHSD17B10 | |
| SCHEMBL1263541 | 0.78 | THRB (0.47) | THRBTSHRALDH1A1TP53HIF1A | |
| SCHEMBL5571975 | 0.77 | PLA2G2A (0.33) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240423878-A2 | SELF-ADHESIVE FISSURE SEALANT | KULZER GMBH (DE) | 2024-12-26 | — | — | US | claimed |
| US-20240216229-A1 | SELF-ADHESIVE FISSURE SEALANT | KULZER GMBH (DE) | 2024-07-04 | — | — | US | claimed |
| EP-4331557-A1 | RADICALLY POLYMERIZABLE COMPOSITION COMPRISING A REDOX INITIATOR SYSTEM BASED ON DIHYDROPYRIDINES | Ivoclar Vivadent AG (LI) | 2024-03-06 | — | — | EP | claimed |
| EP-4331558-A1 | BIOCOMPATIBLE MELT-DENTIN SINGLE COMPONENT ADHESIVES | Ivoclar Vivadent AG (LI) | 2024-03-06 | — | — | EP | claimed |
| US-20240065944-A1 | Biocompatible Enamel-Dentin Single-Component Adhesives | IVOCLAR VIVADENT AG (LI) | 2024-02-29 | — | — | US | claimed |
| EP-4312947-A1 | SELF-ADHESIVE FISSURE SEALANT | Kulzer GmbH (DE) | 2024-02-07 | — | — | EP | claimed |
| US-20220362201-A1 | AGENT FOR PROMOTING ODONTOBLAST PROPAGATION AND DIFFERENTIATION | SUN MEDICAL CO., LTD. (JP) | 2022-11-17 | — | — | US | claimed |
| WO-2022207879-A1 | SELF-ADHESIVE FISSURE SEALANT | KULZER GMBH (DE) | 2022-10-06 | — | — | WO | claimed |
| EP-4049678-A1 | AGENT FOR PROMOTING ODONTOBLAST PROPAGATION AND DIFFERENTIATION | Sun Medical Co., Ltd. (JP) | 2022-08-31 | — | — | EP | claimed |
| CN-114514010-A | Odontoblast proliferation/differentiation promoter | 尚美德齿科材料有限公司 | 2022-05-17 | — | — | CN | claimed |
| WO-2021079988-A1 | AGENT FOR PROMOTING ODONTOBLAST PROPAGATION AND DIFFERENTIATION | サンメディカル株式会社 | 2021-04-29 | — | — | WO | claimed |
| EP-4745210-A1 | FLUORORUBBER TACKINESS AGENT COMPOSITION | Unimatec Co., Ltd. (JP) | 2026-05-20 | — | — | EP | disclosed |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | KURARAY NORITAKE DENTAL INC. (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4029839-B1 | GLASS POWDER AND CHEMICAL POLYMERIZATION INITIATOR | G C DENTAL IND CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260083644-A1 | METHOD FOR PRODUCING DENTAL POLYMERIZABLE COMPOSITION OR DENTAL POLYMERIZABLE COMPOSITION INTERMEDIATE | SHOFU INC (JP) | 2026-03-26 | — | — | US | disclosed |
| WO-2016026915-A1 | LIGHT-CURING DENTAL COMPOSITE WITH INCREASING OPACITY | IVOCLAR VIVADENT AG (LI) | 2016-02-25 | — | — | WO | disclosed |
| WO-2015139811-A1 | MONOMER MIXTURES FOR PRODUCING DENTAL MATERIALS | IVOCLAR VIVADENT AG (LI) | 2015-09-24 | — | — | WO | disclosed |
| WO-2015140276-A1 | PHOTOPOLYMERISABLE AND DUAL CURING DENTAL MATERIALS BASED ON THIOUREA DERIVATIVES | IVOCLAR VIVADENT AG (LI) | 2015-09-24 | — | — | WO | disclosed |
| EP-1462079-B1 | Dental composition | G C DENTAL IND CORP (JP) | 2007-05-23 | — | — | EP | disclosed |
| US-5854318-A | Cement additive, method for producing the same, and cement composition | NIPPON SHOKUBAI KAGAKU KOGYO CO, LTD. (JP) | 1998-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083644-A1 | METHOD FOR PRODUCING DENTAL POLYMERIZABLE COMPOSITION OR DENTAL POLYMERIZABLE COMPOSITION INTERMEDIATE | ARCN1, LBR, POLL | THRB 1247/4885TSHR 3634/4885ALDH1A1 2312/4885 |
| US-20240423878-A2 | SELF-ADHESIVE FISSURE SEALANT | ESD, GFER, FUS | THRB 894/4885TSHR 1186/4885ALDH1A1 318/4885 |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | MSL1, ITGA1, ITGAL | THRB 2959/4885TSHR 4185/4885ALDH1A1 668/4885 |
| US-20220362201-A1 | AGENT FOR PROMOTING ODONTOBLAST PROPAGATION AND DIFFERENTIATION | MKI67, MYADM, HGF | THRB 1537/4885TSHR 4148/4885ALDH1A1 2490/4885 |
| US-20240216229-A1 | SELF-ADHESIVE FISSURE SEALANT | ESD, GFER, FUS | THRB 894/4885TSHR 1186/4885ALDH1A1 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.